BioCentury | May 3, 2017
Financial News

Epic Sciences raises $40M in series D

...Capital Partners, Domain Associates, Genomic Health Inc. (NASDAQ:GHDX), Pagoda Investment, Reach Tone Limited, RMI Partners, Sabby Capital...
BioCentury | Apr 28, 2017
Financial News

Epic raises $40M in series D

...Capital Partners, Domain Associates, Genomic Health Inc. (NASDAQ:GHDX), Pagoda Investment, Reach Tone Limited, RMI Partners, Sabby Capital...
BioCentury | Mar 28, 2016
Financial News

Quantum Genomics completes private placement of common stock and warrants

...million) Shares: 923,644 Price: EUR6 Shares after offering: 7.9 million Placement agent: Maxim Group Investor: Sabby Capital...
BioCentury | Jan 11, 2016
Financial News

Xeris completes venture financing

...Endocrine/Metabolic Date completed: 2016-01-07 Type: Venture financing Raised: $41 million Investors: Redmile Group; Deerfield Management; Sabby Capital...
BioCentury | Jan 8, 2016
Financial News

Crossovers back Xeris in $41M series C

...$41 million in a series C round led by Redmile Group. New investors Deerfield and Sabby Capital...
BioCentury | Sep 21, 2015
Financial News

Aptinyx completes venture financing

...Venture financing Raised: Not disclosed Investors: Cowen; EcoR1 Capital; Goudy Park Capital; Portola Capital Partners; Sabby Capital...
BioCentury | Jun 8, 2015
Financial News

Ardelyx completes private placement of common stock and warrants

...Enterprise Associates; RA Capital Management; Broadfin Capital; Cormorant Asset Management; Foresite Capital; Rock Springs Capital; Sabby Capital...
BioCentury | Jun 4, 2015
Company News

Ardelyx regains tenapanor rights from AZ, raises $77.8M

...Broadfin Capital; Cormorant Asset Management; Foresite Capital; Rock Springs Capital; and a fund managed by Sabby Capital...
BioCentury | Feb 9, 2015
Financial News

Capricor Therapeutics completes private placement

...million Price: $4.25 Shares after offering: 16.2 million Placement agent: H.C. Wainwright Investors: Broadfin Capital; Sabby Capital...
BioCentury | Feb 2, 2015
Emerging Company Profile

Battling blood

...Funds raised: $88.7 million Investors: Third Rock Ventures; Wellington Management Company; RA Capital; Deerfield Management; Sabby Capital...
Items per page:
1 - 10 of 28
BioCentury | May 3, 2017
Financial News

Epic Sciences raises $40M in series D

...Capital Partners, Domain Associates, Genomic Health Inc. (NASDAQ:GHDX), Pagoda Investment, Reach Tone Limited, RMI Partners, Sabby Capital...
BioCentury | Apr 28, 2017
Financial News

Epic raises $40M in series D

...Capital Partners, Domain Associates, Genomic Health Inc. (NASDAQ:GHDX), Pagoda Investment, Reach Tone Limited, RMI Partners, Sabby Capital...
BioCentury | Mar 28, 2016
Financial News

Quantum Genomics completes private placement of common stock and warrants

...million) Shares: 923,644 Price: EUR6 Shares after offering: 7.9 million Placement agent: Maxim Group Investor: Sabby Capital...
BioCentury | Jan 11, 2016
Financial News

Xeris completes venture financing

...Endocrine/Metabolic Date completed: 2016-01-07 Type: Venture financing Raised: $41 million Investors: Redmile Group; Deerfield Management; Sabby Capital...
BioCentury | Jan 8, 2016
Financial News

Crossovers back Xeris in $41M series C

...$41 million in a series C round led by Redmile Group. New investors Deerfield and Sabby Capital...
BioCentury | Sep 21, 2015
Financial News

Aptinyx completes venture financing

...Venture financing Raised: Not disclosed Investors: Cowen; EcoR1 Capital; Goudy Park Capital; Portola Capital Partners; Sabby Capital...
BioCentury | Jun 8, 2015
Financial News

Ardelyx completes private placement of common stock and warrants

...Enterprise Associates; RA Capital Management; Broadfin Capital; Cormorant Asset Management; Foresite Capital; Rock Springs Capital; Sabby Capital...
BioCentury | Jun 4, 2015
Company News

Ardelyx regains tenapanor rights from AZ, raises $77.8M

...Broadfin Capital; Cormorant Asset Management; Foresite Capital; Rock Springs Capital; and a fund managed by Sabby Capital...
BioCentury | Feb 9, 2015
Financial News

Capricor Therapeutics completes private placement

...million Price: $4.25 Shares after offering: 16.2 million Placement agent: H.C. Wainwright Investors: Broadfin Capital; Sabby Capital...
BioCentury | Feb 2, 2015
Emerging Company Profile

Battling blood

...Funds raised: $88.7 million Investors: Third Rock Ventures; Wellington Management Company; RA Capital; Deerfield Management; Sabby Capital...
Items per page:
1 - 10 of 28